Clinical and genetic associations with prostacyclin response in pulmonary arterial hypertension

Clinical and genetic associations with prostacyclin response in pulmonary arterial hypertension

Parenteral prostacyclin therapy is the most efficacious pharmacologic treatment for pulmonary arterial hypertension (PAH), but clinical response is variable. We sought to identify clinical, hemodynamic, and genetic associations with response to prostacyclin therapy. We performed a retrospective anal...

Full description

Bibliographic Details
Main Authors: Stephen J. Halliday, Meng Xu, Timothy E. Thayer, Jonathan D. Mosley, Quanhu Sheng, Fei Ye, Eric H. Farber-Eger, Meredith E. Pugh, Ivan R. Robbins, Tufik R. Assad, James D. West, Evan L. Brittain, Anna R. Hemnes
Format: Article
Language:English
Published: Wiley 2018-09-01
Series:Pulmonary Circulation
Online Access:https://doi.org/10.1177/2045894018800544

Internet

https://doi.org/10.1177/2045894018800544

Similar Items